© 2022 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
September 28, 2022
The destination of Marco Island, Florida not only serves as an excellent backdrop for this year's Ophthalmology Times® EyeCon 2022 but also provides a unique opportunity for family members to see their ophthalmic loved ones in a professional light.
September 21, 2022
Co-chairs Peter J. McDonnell, MD, director of the Wilmer Eye Institute at Johns Hopkins University School of Medicine in Baltimore, Maryland, and Oluwatosin U. Smith, MD, of Glaucoma Associates of Texas in Dallas break down the top reasons to attend this year's Ophthalmology Times® EyeCon 2022 in a series of video segments.
September 18, 2022
Ophthalmologists should instruct their patients to pay attention to their eye health for the long term.
September 16, 2022
Claes H. Dohlman, MD, PhD, widely considered the father of modern cornea science, is a recipient of the 2022 António Champalimaud Vision Award. The award, considered the “Nobel Prize of Vision," comes with a $1 million prize .
September 13, 2022
The ScoutPro system allows eye care practices to minimize tech time and seamlessly integrate osmolarity testing into any practice configuration or patient protocol.
September 01, 2022
Product is forging a future in ocular regenerative procedures
August 26, 2022
The IOL has a hybrid design that combines the benefits of central extended depth-of-focus technology and multifocal technology that provides a continuous range of high-quality vision ranging from distance and intermediate and near vision to about 12 to 14 inches.
August 23, 2022
George Waring IV, MD, FACS, points out that supplementation and customized procedures are in the offing.
August 21, 2022
With a few key steps, surgeons can avert potential refractive surprises, and reduce postoperative dry eye for patients.
August 20, 2022
Reservoir restoration can re establish the normal anatomy and function of the conjunctiva.
Visus Therapeutics expands ophthalmic drug development portfolio with acquisition of ViewPoint Therapeutics' assets
The survey, from The Larry A. Greene Center and the Primary Care Collaborative, found that the COVID-19 pandemic has had an adverse impact on the well-being of physicians.
Myze launches for platform to engage 1 million dry eye patients by 2025: How Do Your Eyes Feel?